68727-745Level 3
VYXEOS ((daunorubicin and cytarabine) liposome)
**Product type:** Human Prescription Drug
**Active ingredient:** CYTARABINE; DAUNORUBICIN
**Strength:** 100; 44 mg/20mL; mg/20mL
**Dosage form:** Injection, Powder, Lyophilized, For Suspension
**Route:** Intravenous
**Labeler:** Jazz Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA209401)
**Pharmacologic class:** Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/68727-745Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.